The current Ebola outbreak in the Democratic Republic of Congo has been devastating, with over 3,000 deaths recorded since mid-May, and nearly half of those infected dying. Children under five years old have particularly high mortality rates, exceeding 60 percent. Doctors Without Borders highlights that children are often excluded from clinical trials for treatments like Obeldesivir, which is being tested for post-exposure prophylaxis after contact with the Bundibugyo strain of the virus. While adjustments to study protocols might include children weighing more than 20 kilograms, younger children remain excluded due to logistical challenges in administering treatments such as Remdesivir. The organization argues that children face unique challenges in diagnosis and treatment, including difficulty in identifying symptoms early and lack of parental support during hospitalization.
Bias read (Progressive): The article emphasizes the disproportionate impact of the Ebola outbreak on children and criticizes the exclusion of young children from medical research and treatment protocols. It advocates for prioritizing children in both prevention and treatment strategies, highlighting systemic gaps in care. S
